3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
6
Neoplasm Metastasis
5
Melanoma
3
Cholangiocarcinoma
3
Breast Neoplasms
3
Sarcoma
2
Osteosarcoma
2
Liver Neoplasms
2
Kidney Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Wilms Tumor
1
Urinary Bladder Neoplasms
1
Unresectable Solid Tumors
1
Solid Tumor, Adult
1
Skin Neoplasms
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Retinoblastoma
1
Rectal Neoplasms
1
Pancreatic Adenocarcinoma Locally Advanced
1
Neuroblastoma
1
Lung Neoplasms
1
Liver Metastasis
1
High-Burden Metastatic Solid Tumors
1
Hepatoblastoma
1
Gastric Cancer Metastatic to Liver
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Desmoid Tumors
1
Colonic Neoplasms
1
Interventions
lenvatinib
3
Fluorouracil
3
Drug Therapy
3
Oxaliplatin
2
Leucovorin
2
Gemcitabine
2
Folfox protocol
2
Floxuridine
2
regorafenib
1
gemcitabine-oxaliplatin regimen
1
durvalumab
1
donafenib
1
apatinib
1
Surgical Procedures, Operative
1
Radiotherapy
1
Dexamethasone
1
Cryosurgery
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Cirrhosis, Familial, with Pulmonary Hypertension
×
Cryosurgery
×
Clear all
NCT07070700
2025-08-12
CASTLE-ZS-02
Fudan University
Phase 2
Recruiting
56 enrolled